Millennium Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Millennium Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-13,348	Closed	-$755K	–	4834
2020 Q1	$755K	Buy	13,348 +9,792	+275%	+$558K	﹤0.01%	2633
2019 Q4	$202K	Sell	3,556 -866	-20%	-$45.9K	﹤0.01%	3880
2019 Q3	$236K	Sell	4,422 -80,115	-95%	-$4.66M	﹤0.01%	3704
2019 Q2	$5.05M	Buy	84,537 +65,237	+338%	+$4.11M	0.01%	1777
2019 Q1	$1.2M	Sell	19,300 -1,689	-8%	-$112K	﹤0.01%	2752
2018 Q4	$1.27M	Buy	+20,989	New	+$1.25M	﹤0.01%	2469
2018 Q3	–	Sell	-35,212	Closed	-$1.58M	–	4454
2018 Q2	$1.58M	Buy	35,212 +10,601	+43%	+$456K	﹤0.01%	2557
2018 Q1	$1.09M	Buy	24,611 +8,698	+55%	+$365K	﹤0.01%	2644
2017 Q4	$690K	Buy	15,913 +7,396	+87%	+$332K	﹤0.01%	2927
2017 Q3	$396K	Buy	8,517 +4,377	+106%	+$210K	﹤0.01%	2949
2017 Q2	$205K	Buy	+4,140	New	+$217K	﹤0.01%	3188
2016 Q2	–	Sell	-19,610	Closed	-$683K	–	3753
2016 Q1	$683K	Buy	19,610 +14,073	+254%	+$516K	﹤0.01%	2366
2015 Q4	$238K	Buy	+5,537	New	+$277K	﹤0.01%	3017
2015 Q2	–	Sell	-13,400	Closed	-$525K	–	4030
2015 Q1	$525K	Buy	13,400 +5,369	+67%	+$210K	﹤0.01%	2724
2014 Q4	$310K	Buy	+8,031	New	+$306K	﹤0.01%	3330
2014 Q3	–	Sell	-10,265	Closed	-$277K	–	4127
2014 Q2	$277K	Buy	+10,265	New	+$267K	﹤0.01%	2920

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management's BSTC Position: Q2 2020 in Review

Millennium Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2020, closing a stake of 13,348 shares — an estimated $755K sold.

Millennium Management first reported a position in BSTC in Q2 2014 and held it in 16 quarters. The position peaked at $5.05M in Q2 2019. 116 funds tracked by Wall St. Rank hold BSTC as of Q2 2020.

Millennium Management reported no remaining BioSpecifics Technologies Corp. position as of Q2 2020 after selling out during the quarter.
Millennium Management sold 13,348 BioSpecifics Technologies Corp. shares in Q2 2020, an estimated $755K.
Millennium Management first reported a position in BioSpecifics Technologies Corp. in Q2 2014 and held it in 16 quarters.
Millennium Management's BioSpecifics Technologies Corp. position peaked at $5.05M in Q2 2019.
116 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2020.

Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.